2023
DOI: 10.3390/cells12232712
|View full text |Cite
|
Sign up to set email alerts
|

Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies

Siqi Zheng,
Erika Guerrero-Haughton,
Floris Foijer

Abstract: Chromosomal instability (CIN) is a prevalent characteristic of solid tumours and haematological malignancies. CIN results in an increased frequency of chromosome mis-segregation events, thus yielding numerical and structural copy number alterations, a state also known as aneuploidy. CIN is associated with increased chances of tumour recurrence, metastasis, and acquisition of resistance to therapeutic interventions, and this is a dismal prognosis. In this review, we delve into the interplay between CIN and canc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 132 publications
(248 reference statements)
0
1
0
Order By: Relevance
“…Targeting mechanisms associated with CIN-driven cancer necessitates strategies to counteract the altered immune landscape, exploit metabolic vulnerabilities, manipulate CIN effects, target the extracellular matrix, and address metastasis and STING signaling pathways. Understanding these molecular mechanisms is paramount for developing effective therapeutic interventions to manage CINdriven cancers and enhance patient outcomes [9].…”
Section: Molecular Mechanisms Underlying Cin Progressionmentioning
confidence: 99%
“…Targeting mechanisms associated with CIN-driven cancer necessitates strategies to counteract the altered immune landscape, exploit metabolic vulnerabilities, manipulate CIN effects, target the extracellular matrix, and address metastasis and STING signaling pathways. Understanding these molecular mechanisms is paramount for developing effective therapeutic interventions to manage CINdriven cancers and enhance patient outcomes [9].…”
Section: Molecular Mechanisms Underlying Cin Progressionmentioning
confidence: 99%